136 related articles for article (PubMed ID: 34193694)
1. Low Expression of Rasal2 Promotes Non-small Cell Lung Cancer Metastasis through Ras/ERK Pathway.
Fan D; Yu S; Yang Y; Qu S
Biol Pharm Bull; 2021; 44(7):992-998. PubMed ID: 34193694
[TBL] [Abstract][Full Text] [Related]
2. CAMSAP2 enhances lung cancer cell metastasis by mediating RASAL2 degradation.
Singharajkomron N; Yodsurang V; Limprasutr V; Wattanathamsan O; Iksen I; Hayakawa Y; Pongrakhananon V
Life Sci; 2024 Feb; 338():122391. PubMed ID: 38159595
[TBL] [Abstract][Full Text] [Related]
3. RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis.
Huang Y; Zhao M; Xu H; Wang K; Fu Z; Jiang Y; Yao Z
Oncotarget; 2014 Aug; 5(16):6734-45. PubMed ID: 25216515
[TBL] [Abstract][Full Text] [Related]
4. miR‑654‑3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non‑small‑cell lung cancer.
Xiong J; Xing S; Dong Z; Niu L; Xu Q; Li Y; Liu P; Yang P
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300072
[TBL] [Abstract][Full Text] [Related]
5. Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.
Wu D; Zhao B; Qi X; Peng F; Fu H; Chi X; Miao QR; Shao S
Cancer Lett; 2018 Apr; 418():135-146. PubMed ID: 29331415
[TBL] [Abstract][Full Text] [Related]
6. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling.
Liu X; Sun L; Zhang S; Zhang S; Li W
J Cell Physiol; 2020 Nov; 235(11):7747-7756. PubMed ID: 31681988
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
8. RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
Hui K; Gao Y; Huang J; Xu S; Wang B; Zeng J; Fan J; Wang X; Yue Y; Wu S; Hsieh JT; He D; Wu K
Cell Death Dis; 2017 Feb; 8(2):e2600. PubMed ID: 28182001
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
10. Blockage of PAK1 alleviates the proliferation and invasion of NSCLC cells via inhibiting ERK and AKT signaling activity.
Song P; Song B; Liu J; Wang X; Nan X; Wang J
Clin Transl Oncol; 2021 Apr; 23(4):892-901. PubMed ID: 32974862
[TBL] [Abstract][Full Text] [Related]
11. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
Zhu X; Guo X; Wu S; Wei L
Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
Pang L; Cheng Y; Zou S; Song J
Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
[TBL] [Abstract][Full Text] [Related]
14. Non-canonical Small GTPase RBJ Promotes NSCLC Progression Through the Canonical MEK/ERK Signaling Pathway.
Wang Y; Shen X; Wang Q; Guo Z; Hu L; Dong Z; Hu W
Curr Pharm Des; 2022; 28(42):3446-3455. PubMed ID: 36397632
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.
Zhang B; Tao F; Zhang H
Mol Med Rep; 2018 Apr; 17(4):4899-4908. PubMed ID: 29393472
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 regulated by ERK pathway mediates TGF-β1-induced EMT in NSCLC.
Kong FF; Zhu YL; Yuan HH; Wang JY; Zhao M; Gong XD; Liu F; Zhang WY; Wang CR; Jiang B
Oncol Res; 2014; 22(1):29-37. PubMed ID: 25700356
[TBL] [Abstract][Full Text] [Related]
17. TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.
Zhang X; He Y; Jiang Y; Bao Y; Chen Q; Xie D; Yu H; Wang X
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184076
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
[TBL] [Abstract][Full Text] [Related]
20. RASAL2 activates RAC1 to promote triple-negative breast cancer progression.
Feng M; Bao Y; Li Z; Li J; Gong M; Lam S; Wang J; Marzese DM; Donovan N; Tan EY; Hoon DS; Yu Q
J Clin Invest; 2014 Dec; 124(12):5291-304. PubMed ID: 25384218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
